Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Pharmaids Pharmaceuticals Ltd
Your Vote -
Buy
60.00%
Hold
30.00%
Sell
10.00%
60.00%
10 users have voted
Option Chain
Analyzes market sentiment, predicts Pharmaids Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Pharmaids Pharma - Announcement Under Reg 30(LODR) - Appointment Of Secretarial Auditor
-
Pharmaids Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 21, 2025.
-
Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Pharmaids Pharma posts Q1 net loss of Rs 4.36 cr
-
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
-
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Change in Management
-
Pharmaids Pharma - Unaudited Financial Results For The Quarter Ended June 30, 2025.
-
Pharmaids Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Dated August 07, 2025.
-
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates
-
Pharmaids Pharma - Updates on Open Offer
-
Pharmaids Pharma - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Con
-
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates
-
Pharmaids Pharma - Updates on Open Offer
-
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates
-
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates
-
Pharmaids Pharma - Letter of Offer
-
Pharmaids Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025
-
Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Pharmaids Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Change in Management
-
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
-
Pharmaids Pharma - Outcome Of The Board Meeting
Key fundamentals
Evaluate the intrinsic value of Pharmaids Pharmaceuticals Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 83.5609 | 22.4252 | 8.6715 | 8.5264 | 8.4331 |
| Liabilities | 83.5609 | 22.4252 | 8.6715 | 8.5264 | 8.4331 |
| Equity | 35.2678 | 21.4438 | 10.2688 | 10.2688 | 10.2688 |
| Gross Profit | -6.3711 | -9.8862 | 0.137 | 0.1069 | -0.3355 |
| Net Profit | -4.9498 | -7.5556 | 0.1451 | 0.0933 | 0.0335 |
| Cash From Operating Activities | -3.4432 | -4.0193 | -0.2593 | 0.4053 | -0.7475 |
| NPM(%) | -17805.03 | 0 | 3.68 | 1.09 | 0 |
| Revenue | 0.0278 | 0 | 3.9392 | 8.551 | 0 |
| Expenses | 6.3989 | 9.8862 | 3.8021 | 8.444 | 0.3355 |
| ROE(%) | -7.37 | -11.25 | 0.21 | 0.13 | 0.04 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Pharmaids Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 808.00 | -1.19 | 73.46 | 35.38 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 97.67 | 9.53 | 315.58 | 128.94 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 22.63 | 0.27 | 0.00 | 267.72 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 913.00 | 11.42 | 0.00 | 121.59 | -604.77 | 0.00 |
Company Info
The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.
The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.
Read More
Parent Organisation
Pharmaids Pharmaceuticals Ltd.
Founded
01/03/1989
Managing Director
NSE Symbol
FAQ
The current price of Pharmaids Pharmaceuticals Ltd is
The 52-week high for Pharmaids Pharmaceuticals Ltd is
The market capitalization of Pharmaids Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Pharmaids Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Pharmaids Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Pharmaids Pharmaceuticals Ltd shares.
The CEO of Pharmaids Pharmaceuticals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
